These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25204853)

  • 1. Multipotent mesenchymal stromal cells in liver cancer: implications for tumor biology and therapy.
    Hernanda PY; Pedroza-Gonzalez A; Sprengers D; Peppelenbosch MP; Pan Q
    Biochim Biophys Acta; 2014 Dec; 1846(2):439-45. PubMed ID: 25204853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
    Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K
    Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications.
    Hogan NM; Dwyer RM; Joyce MR; Kerin MJ
    Int J Cancer; 2012 Jul; 131(1):1-7. PubMed ID: 22290082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells in lung cancer tumor microenvironment: their biological properties, influence on tumor growth and therapeutic implications.
    Liu R; Wei S; Chen J; Xu S
    Cancer Lett; 2014 Oct; 353(2):145-52. PubMed ID: 25128070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy.
    Keung EZ; Nelson PJ; Conrad C
    Stem Cells; 2013 Feb; 31(2):227-35. PubMed ID: 23132810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deepening a Simple Question: Can MSCs Be Used to Treat Cancer?
    Gomes JPA; Assoni AF; Pelatti M; Coatti G; Okamoto OK; Zatz M
    Anticancer Res; 2017 Sep; 37(9):4747-4758. PubMed ID: 28870893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
    Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
    Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
    Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
    Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.
    Yin Z; Jiang K; Li R; Dong C; Wang L
    Mol Cancer; 2018 Dec; 17(1):178. PubMed ID: 30593276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
    Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
    Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irradiation-induced localization of IL-12-expressing mesenchymal stem cells to enhance the curative effect in murine metastatic hepatoma.
    Jeong KY; Lee EJ; Kim SJ; Yang SH; Sung YC; Seong J
    Int J Cancer; 2015 Aug; 137(3):721-30. PubMed ID: 25639194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling.
    Rodríguez R; García-Castro J; Trigueros C; García Arranz M; Menéndez P
    Adv Exp Med Biol; 2012; 741():187-205. PubMed ID: 22457111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic potential of bone marrow-derived mesenchymal stromal cells on hepatocellular carcinoma.
    Bayo J; Marrodán M; Aquino JB; Silva M; García MG; Mazzolini G
    Liver Int; 2014 Mar; 34(3):330-42. PubMed ID: 24112437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells.
    Norozi F; Ahmadzadeh A; Shahrabi S; Vosoughi T; Saki N
    Tumour Biol; 2016 Sep; 37(9):11679-11689. PubMed ID: 27440203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells enhance growth and metastasis of colon cancer.
    Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Kodama M; Higashi Y; Tanaka S; Yasui W; Chayama K
    Int J Cancer; 2010 Nov; 127(10):2323-33. PubMed ID: 20473928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer.
    Bitsika V; Roubelakis MG; Zagoura D; Trohatou O; Makridakis M; Pappa KI; Marini FC; Vlahou A; Anagnou NP
    Stem Cells Dev; 2012 May; 21(7):1097-111. PubMed ID: 21988169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.
    Schmohl KA; Müller AM; Wechselberger A; Rühland S; Salb N; Schwenk N; Heuer H; Carlsen J; Göke B; Nelson PJ; Spitzweg C
    Endocr Relat Cancer; 2015 Dec; 22(6):941-52. PubMed ID: 26307023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.
    Yan C; Yang M; Li Z; Li S; Hu X; Fan D; Zhang Y; Wang J; Xiong D
    Biomaterials; 2014 Mar; 35(9):3035-43. PubMed ID: 24406219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells show little tropism for the resting and differentiated cancer stem cell-like glioma cells.
    Liu Z; Jiang Z; Huang J; Huang S; Li Y; Sheng F; Yu S; Yu S; Liu X
    Int J Oncol; 2014 Apr; 44(4):1223-32. PubMed ID: 24481670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.